<DOC>
	<DOCNO>NCT00104182</DOCNO>
	<brief_summary>This trial conduct Europe United States America ( USA ) . The aim trial compare use Insulin Detemir day ( morning evening ) NPH Insulin day ( even ) add treatment oral antidiabetic drug patient Type 2 diabetes .</brief_summary>
	<brief_title>Comparison Insulin Detemir Morning , Insulin Detemir Evening NPH Insulin Evening Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Isophane insulin , beef</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Isophane Insulin , Human</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>Type 2 diabetes least 12 month Currently treat Oral Antidiabetic Drugs BMI lesser equal 40 kg/m2 HbA1c great equal 7.5 less equal 11 % Proliferative retinopathy maculopathy Recurrent major hypoglycaemia uncontrolled hypertension disease condition ( renal , hepatic cardiac ) accord judgement Investigator make subject unsuitable participation trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>